Skip to main content

Moderate Drinking Linked to Lower Stroke Risk

March 27, 2012 — Light to moderate alcohol consumption is associated with a lower risk for both ischemic and hemorrhagic stroke in women, new research suggests.
"Alcohol consumption in moderation has been consistently associated with lower risk of heart disease, but the data for stroke, especially with regard to stroke type, has been a matter of debate," lead author Monik Jimenez, ScD, from Brigham and Women's Hospital, Boston, Massachusetts, told Medscape Medical News.
The study is published online March 8 in Stroke.
The investigators examined data on 83,578 women in the Nurses' Health Study who were free of diagnosed cardiovascular disease and cancer at baseline. The participants were followed from 1980 to 2006.
Participants provided information about their use of alcohol at baseline and then every 4 years thereafter. They also provided information about lifestyle factors and stroke events every 2 years.
Strokes were classified according to the National Survey of Stroke criteria.
During the study period, there were 2171 incident strokes. Of these, 1206 were ischemic strokes, 363 were hemorrhagic strokes, and 602 were of unknown etiology.
About 30% of the women reported that they never drank alcohol, 35% reported very low levels of consumption (less than 4.9 g/day, or half a glass of wine per day), and 37% drank moderately (5 - 14.9 g/day, or ½ to 1 ½ glasses of wine, 1 mixed drink, or 1 beer daily).
Analysis of the data showed that women who consumed low to moderate amounts of alcohol had a lower risk for total stroke compared with women who never drank.
After adjusting for a number of variables, including smoking, physical activity, body mass index, family and personal history of heart disease, diabetes, hypertension, bilateral oophorectomy, postmenopausal status, hormone therapy, high cholesterol, multivitamin intake, aspirin, composite 6-nutrient diet score, highest level of education, husband's highest level of education, and marital status, the relative risks of stroke were 0.83 (95% confidence interval [CI], 0.75 - 0.92) for women who consumed < 5 g/day, 0.79 (95% CI, 0.70 - 0.90) for 5 to 14.9 g/day, 0.87 (95% CI, 0.72 - 1.05) for 15 to 29.9 g/day, and 1.06 (95% CI, 0.86 - 1.30) for 30 to 45 g/day. Results were similar for ischemic and hemorrhagic stroke.
The estimated risk for stroke in the highest category of reported alcohol intake did not reach statistical significance because there were very few heavy drinkers in the cohort, Dr. Jimenez pointed out.
"Moderate alcohol intake was associated with reduced risk of total stroke, and higher levels were not associated with reduced risk in this particular population, which really emphasizes the importance of moderation if you drink," she said.
"There are several ways that alcohol might reduce the risk of stroke," Dr. Jimenez speculated. "Alcohol has components which prevent blood clots and promote HDL cholesterol, which is the good cholesterol. But alcohol is like a double-edge sword because higher levels can increase high blood pressure and promote atrial fibrillation, which are also risk factors for stroke."
Dr. Jimenez stressed that women who currently do not drink should not start to drink in the belief that this will protect them from stroke.
"Our results are very much in line with the American Heart Association guidelines for up to a glass a day for women, but those recommendations are for women who are current drinkers, and we do not advocate the initiation of alcohol consumption for women who abstain from drinking," she said.
"This paper was based on a very well-done analysis with excellent ascertainment of alcohol exposure," R. Curtis Ellison, MD, professor of medicine at Boston University School of Medicine in Massachusetts, told Medscape Medical News.
"The findings from this study are not that new. Many studies have shown that stroke is in general 10, 15, 20% lower in moderate drinkers," Dr. Ellison said.
"But you have to keep supporting these findings because people are always looking for flaws. Out of 200 or 300 papers, there have been about half a dozen that have not found this, so you have to reinforce your findings. This is a very large study, and it is very useful to have such confirmation."
Dr. Jimenez and Dr. Ellison have disclosed no relevant financial relationships. Dr. Ellison reports that he is a member of the International Scientific Forum on Alcohol Research. The study was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the National Cancer Institute.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...